Current insight into the regulation of PD-L1 in cancer.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported in part by the National Natural Science Foundation of China (No. 81770158, 82070152), the Pearl River S&T Nova Program of Guangzhou, China (No. 201906010002), Guangdong Province Science and Technology Project (No. 2020A0505100042) (No. 2020A1515110310), Guangdong Basic and Applied Basic Research Foundation (No. 2021A1515110140), Special Funds for the Cultivation of Guangdong College Students’ Scientific and Technological Innovation (“Climbing Program” Special Funds.) (No. pdjh2022a0055), and National Innovation and Entrepreneurship Training Program for Undergraduate (No. 202110559101) (No. 202210559061)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025